On the TechTO stage ×1
First seen on the TechTO stage in 2020. Every talk is searchable — ask the archive about David ↗
In their words
We are a tech provider in the space, and what we do is we help to understand how cannabis interacts with medical patients, and how it works recreationally as well.
talk to these people, they're your market, they know best. Don't develop in a vacuum.
common sense is in short supply. There's a lot of whacked out valuations, everyone thinks they know better, but if it doesn't check out, if it's not logical, if it doesn't make sense, it's probably too good to be true.
Quick answers
What is David Berg known for?
Being president and CTO of Strainprint, a Toronto company that crowdsources medical-cannabis outcome data through a patient journaling app and turns it into analytics for clinicians, researchers and licensed producers.
What did he argue at TechTO?
That the cannabis market is cyclical and was going through a bust that would be rebuilt on real economics, and that founders should not develop in a vacuum, should check their assumptions against their market, and should treat things that are too good to be true with suspicion.
What is his background?
A self-described serial entrepreneur with over 20 years leading product and engineering teams, plus hands-on experience in cannabis cultivation and distribution in Canada, Holland and Jamaica. He holds a BCom from York University and an MBA from the University of Windsor.